International
E.U. Reg. Backs Lung Cancer Drug
EUROPE – Astrazeneca said on Friday its cancer drug Enhertu was recommended by the European Medicine Agency’s human medicines committee as a monotherapy to treat patients with a type of non-small cell lung cancer.
-
Court2 days agoMan Sentenced for Killing Mother Loses Bid for a Trial After Taking Plea Deal
-
Court1 day agoDecision Reserved Over Whether Man’s Guilty Conviction Should Be Upheld
-
Court1 day agoMistrial Declared After Jury Failed to Reach Verdict in Child Sex Abuse Trial
-
Court9 hours agoSecond Suspect in 2021 Murder Trial Acquitted
-
Court9 hours agoSentence Reduced in Indecent Assault Case From 3 Years to 2.5 Years
-
International2 days agoCubans Brace for Fuel Scarcity Contingency Measures
-
International2 days agoBad Bunny Joined by Lady Gaga, Ricky Martin in Vibrant Super Bowl Halftime Show
-
International1 day agoJamaica to Enact Policies to Support Contractors in Executing Large Projects






